Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease - Olivier Hermine; Laurent Gros; Truong-An Tran; Lamya Loussaief; Kathleen Flosseau; Alain Moussy; Colin D. Mansfield; Patrick Vermersch (PLoS ONE, 2025)